1. Home
  2. TCRX vs GGR Comparison

TCRX vs GGR Comparison

Compare TCRX & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • GGR
  • Stock Information
  • Founded
  • TCRX 2018
  • GGR 2011
  • Country
  • TCRX United States
  • GGR Taiwan
  • Employees
  • TCRX N/A
  • GGR N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • GGR Auto Manufacturing
  • Sector
  • TCRX Health Care
  • GGR Consumer Discretionary
  • Exchange
  • TCRX Nasdaq
  • GGR Nasdaq
  • Market Cap
  • TCRX 100.7M
  • GGR 114.3M
  • IPO Year
  • TCRX 2021
  • GGR N/A
  • Fundamental
  • Price
  • TCRX $1.44
  • GGR $0.25
  • Analyst Decision
  • TCRX Strong Buy
  • GGR Hold
  • Analyst Count
  • TCRX 6
  • GGR 2
  • Target Price
  • TCRX $9.50
  • GGR $0.50
  • AVG Volume (30 Days)
  • TCRX 470.2K
  • GGR 317.1K
  • Earning Date
  • TCRX 08-11-2025
  • GGR 08-14-2025
  • Dividend Yield
  • TCRX N/A
  • GGR N/A
  • EPS Growth
  • TCRX N/A
  • GGR N/A
  • EPS
  • TCRX N/A
  • GGR N/A
  • Revenue
  • TCRX $4,421,000.00
  • GGR $304,551,000.00
  • Revenue This Year
  • TCRX $159.20
  • GGR N/A
  • Revenue Next Year
  • TCRX N/A
  • GGR $5.00
  • P/E Ratio
  • TCRX N/A
  • GGR N/A
  • Revenue Growth
  • TCRX N/A
  • GGR N/A
  • 52 Week Low
  • TCRX $1.02
  • GGR $0.19
  • 52 Week High
  • TCRX $7.89
  • GGR $1.76
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 44.26
  • GGR 42.72
  • Support Level
  • TCRX $1.44
  • GGR $0.25
  • Resistance Level
  • TCRX $1.61
  • GGR $0.27
  • Average True Range (ATR)
  • TCRX 0.16
  • GGR 0.01
  • MACD
  • TCRX -0.02
  • GGR 0.00
  • Stochastic Oscillator
  • TCRX 10.44
  • GGR 11.15

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: